Literature DB >> 7853632

Helicobacter pylori, gastroduodenal disease, and recurrent abdominal pain in children.

C Macarthur1, N Saunders, W Feldman.   

Abstract

OBJECTIVE: To assess the evidence for a cause-and-effect relationship between Helicobacter pylori infection and antral gastritis, peptic ulcer disease, and recurrent abdominal pain in children. DATA SOURCES: A MEDLINE search from January 1983 through July 1994 was used to identify pertinent English-language publications. Current Contents and selected specialty journals were searched manually. Editorials, reviews, case reports, abstracts, and letters to the editor were excluded. STUDY SELECTION: All studies in children (ie, 0 to 18 years) were included. DATA EXTRACTION: Hill's criteria for causal inference were used to determine the strength of the evidence for a causal relationship. DATA SYNTHESIS: In total, 45 studies (case series, cross-sectional surveys, and treatment trials) were retrieved. The rate ratio of antral gastritis in children with H pylori infection (compared with uninfected children) ranged from 1.9 to 71.0 (median, 4.6). The prevalence of H pylori infection in children with duodenal ulcer was high (range, 33% to 100%; median, 92%) compared with children with gastric ulcer (range, 11% to 75%; median, 25%). Prevalence rates of infection in children with recurrent abdominal pain were inconsistent (range, 0% to 81%; median, 22%), with lower rates in children meeting Apley's criteria (range, 0% to 9%; median, 6%).
CONCLUSIONS: There is strong evidence for an association between H pylori infection and antral gastritis and duodenal ulcer disease in children; however, data from randomized, double-blind, placebo-controlled treatment trials are required. There is weak evidence for an association with gastric ulcer and weak or no evidence for an association with recurrent abdominal pain.

Entities:  

Mesh:

Year:  1995        PMID: 7853632

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  32 in total

Review 1.  How should Helicobacter pylori infected children be managed?

Authors:  M Rowland; C Imrie; B Bourke; B Drumm
Journal:  Gut       Date:  1999-07       Impact factor: 23.059

2.  Helicobacter pylori infection.

Authors:  Yvan Vandenplas
Journal:  World J Gastroenterol       Date:  2000-02       Impact factor: 5.742

Review 3.  New approaches to Helicobacter pylori infection in children.

Authors:  B D Gold
Journal:  Curr Gastroenterol Rep       Date:  2001-06

Review 4.  What do we know about benefits of H. pylori treatment in childhood?

Authors:  Mónica S Sierra; Emily V Hastings; Karen J Goodman
Journal:  Gut Microbes       Date:  2013-11-06

Review 5.  Abdominal migraine: evidence for existence and treatment options.

Authors:  George Russell; Ishaq Abu-Arafeh; David N K Symon
Journal:  Paediatr Drugs       Date:  2002       Impact factor: 3.022

Review 6.  Consequences of Helicobacter pylori infection in children.

Authors:  Lucia Pacifico; Caterina Anania; John F Osborn; Flavia Ferraro; Claudio Chiesa
Journal:  World J Gastroenterol       Date:  2010-11-07       Impact factor: 5.742

7.  Association between gastric atrophy and Helicobacter pylori infection in Japanese children: a retrospective multicenter study.

Authors:  Seiichi Kato; Shigemi Nakajima; Yoshikazu Nishino; Kyoko Ozawa; Takanori Minoura; Mutsuko Konno; Shunichi Maisawa; Shigeru Toyoda; Norikazu Yoshimura; Ajula Vaid; Robert M Genta
Journal:  Dig Dis Sci       Date:  2006-01       Impact factor: 3.199

8.  A review of current guidelines for the management of Helicobacter pylori infection in children and adolescents.

Authors:  Nicola L Jones
Journal:  Paediatr Child Health       Date:  2004-12       Impact factor: 2.253

9.  Helicobacter pylori infection: pediatric aspects.

Authors:  F R Sinatra
Journal:  West J Med       Date:  1997-05

10.  Helicobacter pylori and recurrent pain abdomen.

Authors:  Niranjan Biswal; N Ananathakrishnan; Vikram Kate; S Srinivasan; P Nalini; Betsy Mathai
Journal:  Indian J Pediatr       Date:  2005-07       Impact factor: 1.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.